Intranasal Multiepitope PD‐L1‐siRNA‐Based Nanovaccine: The Next‐Gen COVID‐19 Immunotherapy
Project: ImmuNovation
Updated at: 01-08-2025
Show more
information
Project acronym
ImmuNovation